Related Experiment Video
Updated: Apr 26, 2026

Development of Compendium for Esophageal Squamous Cell Carcinoma
Published on: April 12, 2024
The emerging role of speckle-type POZ protein (SPOP) in cancer development
1Department of Pathology, UT Southwestern Medical Center, Dallas, TX, USA; Department of Urology, UT Southwestern Medical Center, Dallas, TX, USA.
Abstract:
Speckle-type POZ (pox virus and zinc finger protein) protein (SPOP) is an E3 ubiquitin ligase adaptor protein that is frequently mutated in prostate and endometrial cancers. All the cancer-associated SPOP mutations reported to date are clustered in the meprin and TRAF (Tumor necrosis factor receptor-associated factor) homology (MATH) domain, presumably affecting substrate binding. SPOP mutations in prostate cancer are mutually exclusive with the ETS (Erythroblast transformation-specific) family gene rearrangements and define a distinct molecular subclass of prostate cancer. SPOP mutations contribute to prostate cancer development by altering the steady-state levels of key components in the androgen-signaling pathway.
Insights
Speckle-type POZ protein (SPOP) mutations are common in prostate cancer and define a unique subtype. These alterations impact the androgen-signaling pathway, contributing to cancer development.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Speckle-type POZ (pox virus and zinc finger protein) protein (SPOP) functions as an E3 ubiquitin ligase adaptor.
- SPOP is frequently mutated in prostate and endometrial cancers, with mutations clustering in the MATH domain, potentially affecting substrate binding.
- SPOP mutations are mutually exclusive with ETS gene rearrangements in prostate cancer, identifying a distinct molecular subclass.
Purpose of the Study:
- To investigate the role of SPOP mutations in prostate cancer development.
- To understand how SPOP mutations affect the androgen-signaling pathway.
Main Methods:
- Analysis of SPOP mutation data in prostate cancer.
- Investigation of the impact of SPOP mutations on protein interactions and degradation.
- Examination of the androgen-signaling pathway in the context of SPOP mutations.
Main Results:
- SPOP mutations define a distinct molecular subclass of prostate cancer.
- Mutations in SPOP alter the steady-state levels of key components within the androgen-signaling pathway.
- These alterations contribute to prostate cancer development.
Conclusions:
- SPOP mutations play a significant role in prostate cancer pathogenesis.
- Targeting the androgen-signaling pathway may be a therapeutic strategy for SPOP-mutated prostate cancers.
Related Concept Videos
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Adaptive Mechanisms in Cancer Cells
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
mTOR Signaling and Cancer Progression
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Tumor Progression

